This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Will RG, Ironside JW, Zeidler M, Estibeiro K, Cousens SN, Smith PG, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347(9006):921-5.WillRGIronsideJWZeidlerMEstibeiroKCousensSNSmithPGet alA new variant of Creutzfeldt-Jakob disease in the UKLancet1996347(9006)921–510.1016/S0140-6736(96)91412-9Search in Google Scholar
Ward HJ, Everington D, Cousens SN, Smith-Bathgate B, Leitch M, Cooper S, et al. Risk factors for variant Creutzfeldt-Jakob disease: a case-control study. Ann Neurol. 2006;59(1):111-20.WardHJEveringtonDCousensSNSmith-BathgateBLeitchMCooperSet alRisk factors for variant Creutzfeldt-Jakob disease: a case-control studyAnn Neurol200659(1)111–2010.1002/ana.2070816287153Search in Google Scholar
Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216 (4542):136-44. 10.1126/science.6801762PrusinerSBNovel proteinaceous infectious particles cause scrapieScience19822164542136–4410.1126/science.68017626801762Open DOISearch in Google Scholar
Knight R, Will RG. Prion diseases. J Neurol Neurosurg Psychiatry. 2004;75(Suppl 1):36-42. 10.1136/jnnp.2004.036137KnightRWillRGPrion diseasesJ Neurol Neurosurg Psychiatry200475(Suppl 1)36–4210.1136/jnnp.2004.036137176564714978149Open DOISearch in Google Scholar
Popović M. Prionske bolezni pri človeku. Med Razgl. 1997;36:181–9.PopovićMPrionske bolezni pri človekuMed Razgl199736181–9Search in Google Scholar
World Health Organisation. WHO manual for surveillance of human transmissible spongiform encephalopathies including variant Creutzfeldt-Jakob disease, 2003. Accessed January 30th, 2018 at: http://www.who.int/bloodproducts/TSE-manual2003.pdfWorld Health OrganisationWHO manual for surveillance of human transmissible spongiform encephalopathies including variant Creutzfeldt-Jakob disease, 2003. Accessed January 30th2018http://www.who.int/bloodproducts/TSE-manual2003.pdfSearch in Google Scholar
Čakš Jager N. Ocena sistema epidemiološkega spremljanja Creutzfeldt-Jakobove bolezni v Sloveniji: specialistična naloga. Ljubljana: Univerza v Ljubljani, Medicinska fakulteta, 2011.Čakš JagerNOcena sistema epidemiološkega spremljanja Creutzfeldt-Jakobove bolezni v Sloveniji: specialistična nalogaLjubljanaUniverza v Ljubljani, Medicinska fakulteta2011Search in Google Scholar
European Centre for Disease Prevention and Control (ECDC). Creutzfeldt - Jakob disease International Surveillance Network. CJD Surveillance Data 1993-2013. Accessed January 30th, 2018 at: http://www.eurocjd.ed.ac.uk/surveillance%20data%201.htmlEuropean Centre for Disease Prevention and Control (ECDC)Creutzfeldt - Jakob disease International Surveillance Network. CJD Surveillance Data 1993-2013. Accessed January 30th2018http://www.eurocjd.ed.ac.uk/surveillance%20data%201.htmlSearch in Google Scholar
Sikorska B, Knight R, Ironside JW, Liberski PP. Creutzfeldt-Jakob disease. Adv Exp Med Biol. 2012;724:76-90. 10.1007/978-1-4614-0653-2_6SikorskaBKnightRIronsideJWLiberskiPPCreutzfeldt-Jakob diseaseAdv Exp Med Biol201272476–9010.1007/978-1-4614-0653-2_622411235Open DOISearch in Google Scholar
Collins S, McLean CA, Masters CL. Gerstmann-Sträussler-Scheinker syndrome, fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies. J Clin Neurosci. 2001;8(5):387-97.CollinsSMcLeanCAMastersCLGerstmann-Sträussler-Scheinker syndrome, fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathiesJ Clin Neurosci20018(5)387–9710.1054/jocn.2001.091911535002Search in Google Scholar
Will RG. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull. 2003;66(1):255–65. org/10.1093/bmb/66.1.255WillRGAcquired prion disease: iatrogenic CJD, variant CJD, kuruBr Med Bull200366(1)255–65org/10.1093/bmb/66.1.255Open DOISearch in Google Scholar
Hsich G, Kenny K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med. 1996;335(13):924-30.HsichGKennyKGibbsCJLeeKHHarringtonMGThe 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathiesN Engl J Med1996335(13)924–3010.1056/NEJM1996092633513038782499Search in Google Scholar
Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol. 1998;43(1):32-40.ZerrIBodemerMGefellerOOttoMPoserSWiltfangJet alDetection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob diseaseAnn Neurol199843(1)32–4010.1002/ana.4104301099450766Search in Google Scholar
Sanchez-Juan P, Sanchez-Valle R, Green A, Ladogana A, Cuadrado-Corrales N, Mitrova E, et al. Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis. J Neurol. 2007;254:901-6.Sanchez-JuanPSanchez-ValleRGreenALadoganaACuadrado-CorralesNMitrovaEet alInfluence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosisJ Neurol2007254901–610.1007/s00415-006-0472-9277940117385081Search in Google Scholar
Odredba o preventivnih ukrepih v zvezi s transmisivnimi spongiformnimi encefalopatijami. Uradni list RS. 2(12.1.2001):131.Odredba o preventivnih ukrepih v zvezi s transmisivnimi spongiformnimi encefalopatijami. Uradni list RS2(12.1.2001)131Search in Google Scholar
European Centre for Disease Prevention and Control (ECDC). Facts about variant Creutzfeldt-Jakob disease. Accessed March 3rd, 2018 at: https://ecdc.europa.eu/en/vcjd/factsEuropean Centre for Disease Prevention and Control (ECDC)Facts about variant Creutzfeldt-Jakob disease. Accessed March 3rd2018https://ecdc.europa.eu/en/vcjd/factsSearch in Google Scholar
CDC’s Diagnostic Criteria for Creutzfeldt-Jakob Disease (CJD), 2010. Accessed August 30th, 2018 at: https://www.cdc.gov/prions/cjd/diagnostic-criteria.htmlCDC’s Diagnostic Criteria for Creutzfeldt-Jakob Disease (CJD), 2010Accessed August 30th2018https://www.cdc.gov/prions/cjd/diagnostic-criteria.htmlSearch in Google Scholar
Uprava RS za varno hrano, veterinarstvo in varstvo rastlin. Epidemiološko stanje pri BSE v EU in Sloveniji. Accessed January 30th, 2018 at: http://www.uvhvvr.gov.si/si/delovna_podrocja/tse_transimsivne_spongiformne_encefalopatije/epidemiolosko_stanje_pri_bse_v_eu_in_sloveniji/Uprava RS za varno hrano, veterinarstvo in varstvo rastlinEpidemiološko stanje pri BSE v EU in Sloveniji. Accessed January 30th2018http://www.uvhvvr.gov.si/si/delovna_podrocja/tse_transimsivne_spongiformne_encefalopatije/epidemiolosko_stanje_pri_bse_v_eu_in_sloveniji/Search in Google Scholar
World Health Organisation (WHO). Guidelines on tissue infectivity distribution in transmissible spongiform encephalopathies, 2006. Accessed January 30th, 2018 at: http://www.who.int/bloodproducts/TSEPUBLISHEDREPORT.pdfWorld Health Organisation (WHO). Guidelines on tissue infectivity distribution in transmissible spongiform encephalopathies, 2006. Accessed January 30th2018http://www.who.int/bloodproducts/TSEPUBLISHEDREPORT.pdfSearch in Google Scholar
Mitrová E, Belay G. Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development. Acta Virol. 2002;46(1):31-9.MitrováEBelayGCreutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and developmentActa Virol200246(1)31–9Search in Google Scholar
Slivarichová D, Mitrová E, Ursínyová M, Uhnáková I, Koscová S, Wsólová L. Geographic accumulation of Creutzfeldt-Jakob disease in Slovakia - environmental metal imbalance as a possible cofactor. Cent Eur J Public Health. 2011;19(3):158-64.SlivarichováDMitrováEUrsínyováMUhnákováIKoscováSWsólováLGeographic accumulation of Creutzfeldt-Jakob disease in Slovakia - environmental metal imbalance as a possible cofactorCent Eur J Public Health201119(3)158–6410.21101/cejph.a3667Search in Google Scholar
Meiner Z, Kahana E, Baitcher F, Korczyn AD, Chapman J, Cohen OS, et al. Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel. J Neurol. 2011;258(2):255-62. 10.1007/s00415-010-5738-6MeinerZKahanaEBaitcherFKorczynADChapmanJCohenOSet alTau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in IsraelJ Neurol2011258(2)255–6210.1007/s00415-010-5738-6Open DOISearch in Google Scholar
Kojović M, Glavač D, Ožek B, Zupan A, Popović M. De novo P102L mutation in a patient with Gerstmann-Sträussler-Scheinker disease. Eur J Neurol. 2011;18(12):152-3. 10.1111/j.1468-1331.2011.03531.xKojovićMGlavačDOžekBZupanAPopovićMDe novo P102L mutation in a patient with Gerstmann-Sträussler-Scheinker diseaseEur J Neurol201118(12)152–310.1111/j.1468-1331.2011.03531.xOpen DOISearch in Google Scholar
Gubbels S, Bacci S, Laursen H, Hogenhaven H, Cowan S, Molbak K, et al. Description and analysis of 12 years of surveillance for Creutzfeldt–Jakob disease in Denmark, 1997 to 2008. Euro Surveill. 2012;17(15):pii:20142. org/10.2807/ese.17.15.20142-enGubbelsSBacciSLaursenHHogenhavenHCowanSMolbakKet alDescription and analysis of 12 years of surveillance for Creutzfeldt–Jakob disease in Denmark, 1997 to 2008Euro Surveill201217(15)pii:20142org/10.2807/ese.17.15.20142-enOpen DOISearch in Google Scholar
Will RG, Ironside JW, Zeidler M, Estibeiro K, Cousens SN, Smith PG, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347(9006):921-5.WillRGIronsideJWZeidlerMEstibeiroKCousensSNSmithPGet alA new variant of Creutzfeldt-Jakob disease in the UKLancet1996347(9006)921–510.1016/S0140-6736(96)91412-9Search in Google Scholar
Hamlin C, Puoti G, Berri S, Sting E, Harris C, Cohen M, et al. A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2012;79(6):547-52. 10.1212/WNL.0b013e318263565fHamlinCPuotiGBerriSStingEHarrisCCohenMet alA comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob diseaseNeurology201279(6)547–5210.1212/WNL.0b013e318263565f409881222843257Open DOISearch in Google Scholar
The Florey Institute of Neuroscience and Mental Health and The University of Melbourne. Australian national creutzfeldt - jakob disease registry. Accessed January 30th, 2018 at: http://ancjdr.path.unimelb.edu.au/diagnostic-testing/14-3-3-csf-protein-testThe Florey Institute of Neuroscience and Mental Health and The University of MelbourneAustralian national creutzfeldt - jakob disease registry. Accessed January 30th2018http://ancjdr.path.unimelb.edu.au/diagnostic-testing/14-3-3-csf-protein-testSearch in Google Scholar
Loftus T, Chen D, Looby S, Chalissery A, Howley R, Heaney C, et al. CJD surveillance in the Republic of Ireland from 2005 to 2015: a suggested algorithm for referrals. Clin Neuropathol. 2017;36(4):188-94. 10.5414/NP301016LoftusTChenDLoobySChalisseryAHowleyRHeaneyCet alCJD surveillance in the Republic of Ireland from 2005 to 2015: a suggested algorithm for referralsClin Neuropathol201736(4)188–9410.5414/NP30101628332471Open DOISearch in Google Scholar
Kustec T, Keše D, Klavs I. Under-reporting of sexually transmitted infection with chlamydia trachomatis - a revision of surveillance system is required. Zdr Varst. 2016;55(3):174-8. 10.1515/sjph-2016-0022KustecTKešeDKlavsIUnder-reporting of sexually transmitted infection with chlamydia trachomatis - a revision of surveillance system is requiredZdr Varst201655(3)174–810.1515/sjph-2016-0022503106627703536Open DOISearch in Google Scholar
Budka H, Will RG. The end of the BSE saga: do we still need surveillance for human prion diseases? Swiss Med Wkly. 2015;12(145):w14212. 10.4414/smw.2015.14212BudkaHWillRGThe end of the BSE saga: do we still need surveillance for human prion diseases?Swiss Med Wkly201512(145)w1421210.4414/smw.2015.1421226715203Open DOISearch in Google Scholar
